Leriche, Caroline,Auclair, Eric,Le Roux, Jacques,Middlemiss, David
申请号：
AU2011211410
公开号：
AU2011211410B2
申请日:
2011.08.12
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2011211410B220130131.pdf#####10206724_.DOC ABSTRACT The invention is directed to certain novel compounds, methods for producing them 5 and methods for treating or ameliorating a kinase-mediated disorder. More particularly, this invention is directed to substituted triazolopyridine compounds useful as selective kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase-mediated disorder. In particular, the methods relate to treating or ameliorating a kinase-mediated disorder including cardiovascular diseases, diabetes, 0 diabetes-associated disorders, inflammatory diseases, immunological disorders, cancer and diseases of the eye such as retinopathies or macular degeneration or other vitreoretinal diseases, and the like. 5
